                         SEQUENCE LISTING

<110>  SomaLogic, Inc.
 
<120>  Cytidine-5-Carboxamide Modified Nucleotide Compositions and 
       Methods Related Thereto

<130>  0057.65PCT

<150>  US 61/907,274
<151>  2013-11-21

<160>  3     

<170>  PatentIn version 3.5

<210>  1
<211>  131
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  synthetic

<400>  1
ttttttttct tcttctcctt tctcttccca aaatcacacg gacccagggc attctagata       60

tggtttacgc tcaagcgaac ttgccgtcct gagtgtaaag agggaaagag ggcagggtgt      120

ggcatatata t                                                           131


<210>  2
<211>  24
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  primer

<400>  2
atatatatgc cacaccctgc cctc                                              24


<210>  3
<211>  38
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  synthetic


<220>
<221>  misc_feature
<222>  (18)..(22)
<223>  cytidine-5-carboxamide modified nucleotides, these nucleotides 
       may be absent.

<400>  3
gagtgaccgt ctgcctgnnn nncagacgac gagcggga                               38


